NCT05262335 2023-11-28
ALTER-G-001
Ruijin Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT04755543 2021-02-16
A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms
Taizhou HoudeAoke Biomedical Co., Ltd.
Phase 1 Unknown
NCT02644863 2016-05-24
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase 2 Unknown